+43.0%
CVS vs CTSH
+2.4%
+40.7%
-44.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CTSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.7% | -1.7% | +3.4% | +1.7% |
| 7D | -3.7% | -2.3% | -1.4% | -3.6% |
| 30D | -0.3% | +7.4% | -7.8% | -0.8% |
| 3M | -10.3% | +10.9% | -21.2% | -10.9% |
| 6M | -4.6% | +24.7% | -29.3% | -6.0% |
| YTD | +10.7% | -22.0% | +32.7% | +16.3% |
| 1Y | +11.2% | -11.2% | +22.4% | +13.7% |
| 3Y | +43.0% | +3.9% | +39.2% | +37.6% |
| All | +43.0% | +2.4% | +40.7% | +37.6% |
Cumulative growth
Daily Returns
Daily percentage return beside CTSH.
Daily Out/Under-Performance
Portfolio return minus CTSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CTSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CTSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling